Non-Invasive Prenatal Testing (NIPT) Market by Product and Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) – Global Forecast to 2027

  • Report ID:MRHC - 104369
  • Pages: 191
  • Feb 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction
    1.1. Market Definition
    1.2. Market Ecosystem
    1.3. Currency
    1.4. Key Stakeholders

2. Research Methodology
    2.1. Research Approach
    2.2. Data Collection & Validation
           2.2.1. Secondary Research
           2.2.2. Primary Research
    2.3. Market Assessment
           2.3.1. Market Size Estimation
                    2.3.1.1. Bottom-Up Approach
                    2.3.1.2. Top-Down Approach
                    2.3.1.3. Growth Forecast
           2.3.2. Market Share Analysis
    2.4. Assumptions for the Study
    2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Drivers
           4.2.1. Increase in Progressive Maternal Age
           4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Fetus
           4.2.3. Development of Advanced Non-Invasive Prenatal Testing Products
    4.3. Restraint
           4.3.1. High Cost of The Non-Invasive Prenatal Screening Services
    4.4. Opportunity
           4.4.1. Untapped Emerging Markets
    4.5. Challenge
           4.5.1. Reliability of the NIPT Tests

5. Non-Invasive Prenatal Testing Market, by Product and Solutions
    5.1. Introduction
    5.2. Test Kits/Consumables
    5.3. Systems
           5.3.1. Nuchal Translucency Ultrasound Devices
           5.3.2. Next-Generation Sequencing Systems
           5.3.3. Polymerase Chain Reaction Instruments
           5.3.4. Microarrays
    5.4. Software

6. Non-Invasive Prenatal Testing Market, by Method
    6.1. Introduction
    6.2. Cell-Free DNA Screening
    6.3. Ultrasound Screening

7. Non-Invasive Prenatal Testing Market, by Application
    7.1. Introduction
    7.2. Trisomy Detection
    7.3. Sex Chromosomal Abnormalities
    7.4. Microdeletion Syndrome
    7.5. Other Applications

8. Non-Invasive Prenatal Testing Market, by End User
    8.1. Introduction
    8.2. Diagnostic Laboratories
    8.3. Hospitals
    8.4. Academic and Research Institutes

9. Global Non-Invasive Prenatal Testing Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. U.K.
           9.3.3. France
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. China
           9.4.2. Japan
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Latin America
    9.6. Middle East and Africa

10. Competitive Landscape
    10.1. Introduction
    10.2. Key Growth Strategies
    10.3. Competitive Benchmarking
    10.4. Market Share Analysis (2018)

11. Company Profiles
      11.1. Illumina, Inc.
               11.1.1. Business Overview
               11.1.2. Financial Overview
               11.1.3. Product Portfolio
               11.1.4. Strategic Developments
      11.2. Thermo Fisher Scientific Inc.
               11.2.1. Business Overview
               11.2.2. Financial Overview
               11.2.3. Product Portfolio
               11.2.4. Strategic Developments
      11.3. Agilent Technologies, Inc.
               11.3.1. Business Overview
               11.3.2. Financial Overview
               11.3.3. Product Portfolio
      11.4. GE Healthcare
               11.4.1. Business Overview
               11.4.2. Financial Overview
               11.4.3. Product Portfolio
               11.4.4. Strategic Developments
      11.5. PerkinElmer, Inc.
               11.5.1. Business Overview
               11.5.2. Financial Overview
               11.5.3. Product Portfolio
      11.6. Beijing Genomics Institute
               11.6.1. Business Overview
               11.6.2. Product Portfolio
               11.6.3. Strategic Developments
      11.7. Eurofins LifeCodexx (A Subsidiary of Eurofins Scientific SE)
               11.7.1. Business Overview
               11.7.2. Financial Overview
               11.7.3. Product Portfolio
      11.8. Natera, Inc.
               11.8.1. Business Overview
               11.8.2. Financial Overview
               11.8.3. Product Portfolio
               11.8.4. Strategic Developments
      11.9. Igenomix, S.L.
               11.9.1. Business Overview
               11.9.2. Product Portfolio
               11.9.3. Strategic Developments
       11.10. Laboratory Corporation of America Holdings
                 11.10.1. Business Overview
                 11.10.2. Financial Overview
                 11.10.3. Product Portfolio
                 11.10.4. Strategic Developments
       11.11. F. Hoffman-La Roche Ltd.
                 11.11.1. Business Overview
                 11.11.2. Financial Overview
                 11.11.3. Product Portfolio
                 11.11.4. Strategic Developments
       11.12. Yourgene Health plc.
                 11.12.1. Business Overview
                 11.12.2. Financial Overview
                 11.12.3. Product Portfolio
                 11.12.4. Strategic Developments

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Table

Table 1  Global Non-Invasive Prenatal Testing Market: Impact Analysis of Market Drivers (2019–2027)
Table 2  Live Births by Mother’s Age
Table 3  Ongoing Studies for Non-Invasive Prenatal Testing (February 2019)
Table 4  Global Non-Invasive Prenatal Testing Market: Impact Analysis of Market Restraint (2019–2027)
Table 5  Cost of NIPT Screening Services, by Country
Table 6  Detection Rates and False Positive Rates of Major Aneuploidies Using NIPT 
Table 7  Relation Between Cell-Free Fetal DNA Content and Body Mass Index
Table 8  Performance Estimates of NIPT Test, By Company
Table 9  Global Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 10 Key Companies Offering NIPT Kits / Consumables
Table 11 Global Non-Invasive Prenatal Testing Kits / Consumables Market Size, by Country/Region, 2017-2027 ($Million)
Table 12 Global Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 13 Global Non-Invasive Prenatal Testing Systems Market Size, by Country/Region, 2017-2027 ($Million
Table 14 Key Companies Offering Nuchal Translucency Ultrasound Devices
Table 15 Global Nuchal Translucency Ultrasound Devices Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 16 Developments by Key Players (2017-2019)
Table 17 Key Companies Offering NGS-Based Non Invasive Prenatal Testing (NIPT) Market Products
Table 18 Global Next-Generation Sequencing Systems Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 19 Key Companies Offering PCR-Based Non Invasive Prenatal Testing (NIPT) Market Products
Table 20 Global Polymerase Chain Reaction Systems Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 21 Global Microarrays Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 22 Key Companies Offering Non Invasive Prenatal Testing (NIPT) Market Software
Table 23 Global Non-Invasive Prenatal Testing Software Market Size, by Country/Region, 2017-2027 ($Million)
Table 24 Global Non Invasive Prenatal Testing (NIPT) MarketSize, by Method, 2017-2027 ($Million)
Table 25 Comparison of Cf DNA Method with Serum Screening
Table 26 Technologies Used by Key Players
Table 27 Comparison of Cost for the Non Invasive Prenatal Testing (NIPT) Market Methods
Table 28 Global Cell-Free DNA Screening Market Size, by Country, 2017-2027 ($Million)
Table 29 Global Ultrasound Screening Market Size, by Country/Region, 2017-2027 ($Million)
Table 30 Global Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 31 Comparison of Performance of Invasive and Non-Invasive Methods for Trisomy Detection
Table 32 Comparison of Accuracy of Non Invasive Prenatal Testing (NIPT) Market for Detection of Aneuploidies
Table 33 Comparison of Cost of Non Invasive Prenatal Testing (NIPT) Market for Aneuploidies
Table 34 New Product Launches (2017-2019)
Table 35 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Trisomy Detection
Table 36 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Trisomy Detection, by Country/Region, 2017-2027 ($Million)
Table 37 Prevalence of Sex Chromosomal Abnormalities
Table 38 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Sex Chromosomal Abnormalities
Table 39 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Sex Chromosomal Abnormalities, by Country/Region, 2017-2027 ($Million)
Table 40 Risks of Occurrence of Microdeletion Abnormalities with Mother’s Age
Table 41 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Microdeletion Syndrome
Table 42 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Microdeletion Syndrome, by Country/Region, 2017-2027 ($Million)
Table 43 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Other Applications, by Country/Region, 2017-2027 ($Million)
Table 44 Global Non Invasive Prenatal Testing (NIPT) Market Market Size, by End User, 2017-2027 ($Million)
Table 45 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Diagnostic Laboratories, by Country/Region, 2017-2027 ($Million)
Table 46 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Hospitals, by Country/Region, 2017-2027 ($Million)
Table 47 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Academic and Research Institutes, by Country/Region, 2017-2027 ($Million)
Table 48 Global Non Invasive Prenatal Testing (NIPT) Market Size, by Country/ Region, 2017-2027 ($Million)
Table 49 R&D Expenditures in North American Countries (2018)
Table 50 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Country, 2017-2027 ($Million)
Table 51 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 52 North America: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 53 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 54 North America: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 55 North America: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 56 Commercial Landscape of Non-Invasive Prenatal Testing for Fetal Aneuploidy in the U.S.
Table 57 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in the U.S.
Table 58 U.S.: Key Macroindicators
Table 59 U.S.: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 60 U.S.: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 61 U.S.: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 62 U.S.: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 63 U.S.: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 64 Funding Status of Non-Invasive Prenatal Testing in Some Provinces of Canada (2018)
Table 65 Characteristics of the Panorama and Harmony Noninvasive Prenatal Tests (2018)
Table 66 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in Canada
Table 67 Canada: Key Macroindicators
Table 68 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 69 Canada: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 70 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 71 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 72 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 73 Cost of Non Invasive Prenatal Testing (NIPT) Market Services in the European Countries
Table 74 Europe: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Country, 2017-2027 ($Million)
Table 75 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 76 Europe: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 77 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 78 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 79 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 80 Cost of Non Invasive Prenatal Testing (NIPT) Market in Germany
Table 81 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in Germany
Table 82 Germany: Key Macroindicators
Table 83 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Product, 2017-2027 ($Million)
Table 84 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Type, 2017-2027 ($Million)
Table 85 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Method, 2017-2027 ($Million)
Table 86 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Application, 2017-2027 ($Million)
Table 87 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by End User, 2017-2027 ($Million)
Table 88 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in the U.K.
Table 89 U.K.: Key Macroindicators
Table 90 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 91 U.K.: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 92 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 93 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 94 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 95 Companies and Laboratories Providing NIPT Products in France
Table 96 France: Key Macroindicators
Table 97 France: NIPT Market Size, by Product, 2017-2027 ($Million)
Table 98 France: NIPT Systems Market Size, by Type, 2017-2027 ($Million)
Table 99 France: NIPT Market Size, by Method, 2017-2027 ($Million)
Table 100 France: NIPT Market Size, by Application, 2017-2027 ($Million)
Table 101 France: NIPT Market Size, by End User, 2017-2027 ($Million)
Table 102 Companies and Laboratories Providing NIPT Products in Italy
Table 103 Italy: Key Macroindicators
Table 104 Italy: NIPT Market Size, by Product, 2017-2027 ($Million)
Table 105 Italy: NIPT Systems Market Size, by Type, 2017-2027 ($Million)
Table 106 Italy: NIPT Market Size, by Method, 2017-2027 ($Million)
Table 107 Italy: NIPT Market Size, by Application, 2017-2027 ($Million)
Table 108 Italy: NIPT Market Size, by End User, 2017-2027 ($Million)
Table 109 Companies and Laboratories Providing NIPT Products in Spain
Table 110 Spain: Key Macroindicators
Table 111 Spain: NIPT Size, by Product, 2017-2027 ($Million)
Table 112 Spain: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 113 Spain: NIPT Size, by Method, 2017-2027 ($Million)
Table 114 Spain: NIPT Size, by Application, 2017-2027 ($Million)
Table 115 Spain: NIPT Size, by End User, 2017-2027 ($Million)
Table 116 Comparison of Classical Down Syndrome Screening (FTS/ Invasive Testing) Versus NIPT In Belgium
Table 117 Rest of Europe: NIPT Size, by Product, 2017-2027 ($Million)
Table 118 Rest of Europe: Non-Invasive Prenatal Testing Systems Market Size, by Type 2017-2027 ($Million)
Table 119 Rest of Europe: NIPT Size, by Method, 2017-2027 ($Million)
Table 120 Rest of Europe: NIPT Size, by Application, 2017-2027 ($Million)
Table 121 Rest of Europe: NIPT Size, by End User, 2017-2027 ($Million)
Table 122 Asia-Pacific: NIPT Size, by Country, 2017-2027 ($Million)
Table 123 Asia-Pacific: NIPT Size, by Product, 2017-2027 ($Million)
Table 124 Asia-Pacific: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 125 Asia-Pacific: NIPT Size, by Method, 2017-2027 ($Million)
Table 126 Asia-Pacific: NIPT Size, by Application, 2017-2027 ($Million)
Table 127 Asia-Pacific: NIPT Size, by End User, 2017-2027 ($Million)
Table 128 Number of New Labs Established Per Year (2013-2017)
Table 129 Companies and Laboratories Providing NIPT Products in China
Table 130 China: Key Macroindicators
Table 131 China: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 132 China: Non-Invasive Prenatal Testing Systems Market Size, by Type 2017-2027 ($Million)
Table 133 China: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 134 China: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 135 China: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 136 Companies and Laboratories Providing NIPT Products in Japan
Table 137 Japan: Key Macroindicators
Table 138 Japan: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 139 Japan: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 140 Japan: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 141 Japan: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 142 Japan: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 143 Companies and Laboratories Providing NIPT Products in India
Table 144 India: Key Macroindicators
Table 145 India: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 146 India: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 147 India: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 148 India: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 149 India: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 150 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 151 ROAPAC: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 152 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 153 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 154 ROAPAC: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 155 Companies and Laboratories Providing NIPT Products in Latin America
Table 156 Latin America: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 157 Latin America: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 158 Latin America: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 159 Latin America: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 160 Latin America: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 161 Scenario of NIPT in Middle East & African Countries
Table 162 Cost of NIPT Services in Middle East and African Countries
Table 163 Companies Offering NIPT Products in Middle East & Africa
Table 164 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 165 Middle East & Africa: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 166 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 167 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 168 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 169 Number of Developments by the Major Players During 2016-2019

List of Figure

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 5 Market Sizing and Growth Forecast Approach
Figure 6 Kits / Consumables Segment Dominates the Global Non-Invasive Prenatal Testing Market
Figure 7 Global Non-Invasive Prenatal Testing Market Size, by Method, 2019-2027 ($Million)
Figure 8 Global Non-Invasive Prenatal Testing Market Size, by Application, 2019-2027 ($Million)
Figure 9 Diagnostic Laboratories Segment Will Dominate the Global Non-Invasive Prenatal Testing Market during the Forecast Period
Figure 10 Non-Invasive Prenatal Testing Market, by Region
Figure 11 Market Dynamics
Figure 12 Increasing Prevalence of Trisomy 21 (Down Syndrome) with Increasing Maternal Age
Figure 13 Trisomy Incidences (2015-2017)
Figure 14 Strategies by Key Players, (2016-2019)
Figure 15 Increasing Healthcare Expenditure (% GDP) in Asia (2014-2016)
Figure 16 Global Non-Invasive Prenatal Testing Market Size, by Product, 2019-2027 ($Million)
Figure 17 Increasing Prevalence of Chromosomal Abnormalities (2015-2017)
Figure 18 Global Non-Invasive Prenatal Testing Market Size, by Method, 2019-2027 ($Million)
Figure 19 Ultrasound Screening Method in All Trimesters
Figure 20 Global Non-Invasive Prenatal Testing Market Size, by Application, 2019-2027 ($Million)
Figure 21 Increasing Incidences of Trisomy (2015-2017)
Figure 22 Global NIPT Market Size, by End User, 2019-2027 ($Million)
Figure 23 Prevalence of Chromosomal Abnormalities (2015-2017)
Figure 24 Global Non-Invasive Prenatal Testing Market Size, by Region, 2019-2027 ($Million)
Figure 25 North America: Healthcare Expenditure, % GDP (2013-2016)
Figure 26 North America: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 27 Europe: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 28 Developments in the Prenatal Screening Area in the U.K. (2018)
Figure 29 Some of the Recent Competitive Developments for NIPT in France, (2016-2019)
Figure 30 Asia-Pacific: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 31 Scenario of the Chromosomal Abnormalities in India
Figure 32 Key Growth Strategies Adopted by Leading Players, 2016-2019
Figure 33 Non-Invasive Prenatal Testing Market: Competitive Benchmarking
Figure 34 Global Non-Invasive Prenatal Testing Kits / Consumables Market Share, by Key Players, 2018 (%)
Figure 35 Illumina, Inc.: Financial Overview (2016-2018)
Figure 36 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2016-2018)
Figure 38 GE Healthcare: Financial Overview (2016-2018)
Figure 39 PerkinElmer Inc.: Financial Overview (2016-2018)
Figure 40 Eurofins Scientific SE: Financial Overview (2016-2018)
Figure 41 Natera Inc.: Financial Overview (2016-2018)
Figure 42 Laboratory Corporation of America Holdings: Financial Overview (2016-2018)
Figure 43 F. Hoffmann-La Roche Ltd.: Financial Overview (2016-2018)
Figure 44 Yourgene Health plc.: Financial Overview (2017-2019)

COVID-19

We are in the phase of updating this report by analysing the impact of COVID-19 on this market.

Speak with our analysts to know more here

The global non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019 to 2027 to reach $13.1 billion by 2027. Non-invasive prenatal testing (NIPT) is a method of determining the risk that the fetus will be born with certain genetic abnormalities. It analyzes small fragments of DNA circulating in a pregnant woman’s blood.

The growth in the Non Invasive Prenatal Testing (NIPT) market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced non-invasive parenteral testing products, and improvement in reimbursement scenario for NIPT. Furthermore, rising awareness regarding non-invasive prenatal testing and untapped market potential in emerging economies across Asia offers significant revenue growth opportunities for the players operating in this market.

High risk of chromosomal abnormalities with increasing maternal age is propelling the growth of non-invasive prenatal testing market

Pregnancy in advanced age is defined as childbirth at the age of approximately 35 years or older; regardless of whether the childbirth is the first or not. The proportion of women conceiving at or above the age of 35 in prenatal medical and obstetrical services has increased significantly over the past 30 years. This demographic change has had important implications to women planning a pregnancy and may also lead to several chromosomal abnormalities. For instance, the chance of having a child with Down syndrome increases over time. The risk is about 1 in 1,250 for a woman who conceives at the age 25. It increases to about 1 in 100 for a woman who conceives at age 40.

As the percentages of pregnancies in women of advanced age have increased, there has been increasing demand for prenatal genetic counseling that helps to predict the risk of fetal chromosomal abnormalities depending on age, thereby fueling the growth in the non-invasive prenatal testing market.

Click here to: Get Sample Copy of this report

Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products

Prenatal testing has been moving toward non-invasive methods to determine the fetal risk for genetic disorders without incurring the risk of miscarriage. Progress of modern molecular technologies and the discovery of cell-free fetal DNA in maternal plasma have led to novel screening methods for fetal chromosomal aneuploidies. With increasing throughput and lowering cost, NGS technology together with cffDNA analysis has paved the way for detection of chromosomal aberrations. There is a steady growth in development of advanced technologies for NIPT owing to the growing awareness regarding the advantages of non-invasive methods. Major players in the market are focusing on strategies for development of new products and technologies for non-invasive parenteral testing. For instance,

  • In June 2019, BGI Genomics along with Eluthia launched the NIFTY test, under the brand name PreviaTest in Germany having sensitivity rate of over 99% to expand access and to increase sales of non-invasive products in Germany.
  • In January 2019, Illumina expanded its NIPT platform portfolio with the launch of its VeriSeq NIPT Solution v2.
  • In July 2018, Berry Genetics partnered with 10X Genomics to upgrade non-invasive DNA prenatal testing and thereby entered into the Chinese market.

Key Findings in the Global Non-Invasive Prenatal Testing Market Study:

NIPT kits/consumables segment to dominate the non-invasive prenatal testing market through 2027

Based on the product and solution, NIPT market is categorized into consumables, systems, and software. In 2019, the kits/consumables segment dominated the overall NIPT market. The growth of this segment is mainly driven by factors such as increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.

Based on application, Trisomy segment to dominate the non-invasive prenatal testing market through 2027

The largest share of this segment is mainly attributed to factors such as increasing incidences of trisomies in babies associated with progressive maternal age in recent years.

Diagnostic laboratories dominated the non-invasive prenatal testing market in 2019

The growing preference of utilizing NIPT services of diagnostic laboratories by gynecologists and patients reflects the dominant position of this end user segment in the overall NIPT market in 2019. Availability of well-equipped facility and trained/skilled laboratory technicians have led to greater volume of tests being outsourced to diagnostic labs; consequently, driving larger share of this segment. Further, the increasing number of initiatives taken by diagnostic laboratories to provide safe and effective prenatal tests is expected to support the growth of NIPT market among diagnostic labs over the forecast period.

North America: The largest regional market

Your browser does not support the canvas element.

North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Growing occurrence of genetic disorders in newborns associated with increasing maternal age, rising awareness about NIPT, technological advancements in NIPT technologies, and magnificent government spending for research and development (R&D) activities are the key factors contributing to the largest share of this region.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.).

Scope of the Report:

Non-Invasive Prenatal Testing Market by Product & Solutions

  • Kits / Consumables
  • Systems
    • Nuchal Translucency Ultrasound Devices
    • Next Generation Sequencing Systems
    • Microarrays
    • Polymerase Chain Reaction Instruments
  • Software

Market by Non-Invasive Prenatal Testing Method

  • Ultrasound Screening
  • Cell-free DNA Screening

Non-Invasive Prenatal Testing Market by Application

  • Trisomy Detection
  • Microdeletions Syndrome
  • Sex Chromosomal Abnormalities
  • Other Applications

Note: Other applications include sex determination and cystic fibrosis

Non-Invasive Prenatal Testing Market by End User

  • Diagnostic Laboratories
  • Hospitals
  • Academic and Research Institutes

Non-Invasive Prenatal Testing Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Key questions answered in the report-

Increase in maternal age and growing incidences of chromosomal abnormalities to drive the NIPT market

  • How does the progressive maternal age drive the growth of NIPT market?
  • How government initiatives and investment in women health bolstering the NIPT market in developing and developed regions?

Cell Free DNA Test accounted for the largest share of the NIPT market

  • What factors are contributing to the frequent usage of Cell Free DNA Test for NIPT application?
  • How does the adoption of cf-DNA screening method differ from ultrasound screening?

The Asia-Pacific NIPT market favors both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What factors are driving growths and which market segments have the most potential for revenue expansion over the forecast period?
  • What are the major drivers, restraints, challenges, and opportunities, in the global NIPT market?
  • What are the key geographical trends and which are the high growth regions/countries?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: NIPT market Non Invasive Prenatal Testing Market Ultrasound Screening Sex Chromosome Abnormalities Trisomy Medical Technologies Non-Invasive Prenatal Testing Market
Download Free Sample